MEC Company Ltd. (4971.T): Company Profile

Source disclosure: live data via yfinance and company IR materials as of 2026-05-12. Financials in JPY unless noted. FY = calendar year (Dec year-end).

PS 2026-05-12

Source disclosure: live data via yfinance and company IR materials as of 2026-05-12. Financials in JPY unless noted. FY = calendar year (Dec year-end).

1. Corporate Overview

MEC Company Ltd. (4971.T) is a Japanese specialty chemicals company that sells microetching and surface-treatment chemistries to the printed circuit board and IC substrate supply chain. The franchise sits on one product family — the CZ-series copper microetchant — which has effectively monopolised inner-layer copper roughening for high-end multilayer PCBs and ABF-style substrate cores for two decades. Per sponsored research, MEC claims ~100% global share in copper surface treatment for PC CPU substrates, and CZ-series accounts for roughly half of corporate revenue.

The pitch in one line: MEC sells a few hundred yen of chemistry per substrate panel, but it is the chemistry that lets PCB houses hit the adhesion, dielectric-loss and laser-drill specs that AI servers, ABF substrates and 5G AiP modules now demand. Layer-count expansion, finer line/space, and tighter dielectric-loss targets all increase consumption intensity per board — a volume-and-mix tailwind, not just a unit-growth story.

Field	Value
Legal name	MEC Company Ltd.
Ticker	4971.T (TSE Prime)
GICS	Materials / Specialty Chemicals
HQ	Amagasaki, Hyogo, Japan
Founded	1969
Employees	508 (Dec-2025)
Currency	JPY
Website	https://www.mec-co.com
Latest IR deck	2030 Vision Phase 2 (Feb 13, 2026)

Business lines (no formal segment disclosure beyond geography; product mix per IR commentary):

CZ-series microetchants / adhesion enhancement — copper roughening for multilayer PCB inner layers, ABF/BT IC substrate cores, high-frequency substrates. ~50% of revenue.
AMALPHA — proprietary metal-to-resin direct bonding chemistry. Smaller revenue contributor today; positioned as the future structural-bonding play (5G AiP, power modules, EV battery cell packs).
V-Bond series — environment-friendly alternative to black oxide; legacy multilayer PCB application.
Other surface-treatment chemistries — pre-lamination treatment, DFR pre-treatment, laser-direct-drilling copper prep, degreasing/anti-tarnish, residue removers.
Process equipment — small business; spray/dip processing lines sold alongside chemistries to PCB shops.

Business model. Recurring consumable chemistry sold by the litre/kg through long-qualified specifications at PCB and substrate fabs. Customers cannot swap suppliers without re-qualifying the board recipe with their end-customer (Intel, AMD, Nvidia, Apple, etc.) — high switching cost, low individual ASP. Gross margin 61.6% (FY2025); operating margin 27.4% (FY2025) — a software-grade margin profile for a chemicals business, which is the signal that this is closer to a specialty platform than a commodity etchant.

Geographic revenue mix (six reporting bases): Japan, Taiwan, Suzhou (China), Zhuhai (China), Thailand, Europe. Asia ex-Japan is the majority — Taiwan + Suzhou is where the highest-end PCB and ABF substrate work happens.

Assets & Operations Footprint

Amagasaki HQ + Japan plant — R&D and core production.
Taiwan plant — supports Taiwanese PCB cluster (Tripod, Compeq, Nan Ya PCB, Unimicron).
Suzhou (China) — expansion underway, +~30% capacity by Dec-2026 per the medium-term plan, targeting AI server PCB and substrate demand.
Zhuhai (China) — south China PCB cluster.
Thailand — south-east Asia PCB customers.
Europe — small, services European HDI demand.
Kitakyushu (new, Japan) — under construction; scheduled to start operations Dec 2026. Initial costs and depreciation are explicitly factored into the 2027 operating-margin guidance.

Asset map / facility deck is inside the Feb-2026 medium-term plan PDF (linked above); no clean public-URL image to embed.

Joint Ventures & Strategic Partnerships

None disclosed at the corporate level. MEC operates wholly-owned subsidiaries in each geography rather than JVs. Commercial relationships with PCB fabs are pure supplier–customer, not equity-linked.

2. Key Customers & Partners

MEC does not publicly disclose named customers. The customer list is inferred from end-use commentary (AI server PCB, IC substrate, 5G AiP) and the PCB/substrate cluster geography. Treat as inference, not disclosure.

#	Likely Customer	Ticker	Est. Revenue Share	Relationship Type
1	Ibiden	4062.T	not disclosed	ABF IC substrate — CZ for substrate cores
2	Unimicron	3037.TW	not disclosed	ABF IC substrate + HDI PCB
3	Compeq / Tripod / Nan Ya PCB	2313.TW / 3044.TW / 8046.TW	not disclosed	AI server HDI PCB
4	Shinko Electric	6967.T	not disclosed	IC substrate
5	Kinsus / Simmtech	3189.TW / KQ:222800	not disclosed	IC substrate, memory substrate

Concentration risk. Undisclosed. The CZ ~100% market-share claim implies that any single ABF substrate house is a meaningful customer, and Ibiden + Unimicron together likely sit at the top — but MEC has not given a top-customer % publicly.

Dependency flag. If MEC’s customers (Ibiden, Unimicron) lose substrate share to Korean or Chinese substrate entrants who specify different surface-treatment chemistries, MEC loses with them — even though MEC has no direct competitive issue with the new entrants.

3. Why It Matters — End Markets & TAM

Why it matters. Every advanced multilayer PCB and IC substrate built today needs a roughened copper surface so the next dielectric layer adheres without delaminating. As line/space shrinks (HDI → mSAP → ABF) and dielectric loss budgets tighten (M9-grade CCL, Megtron 8/M9), the conventional brown-oxide roughening process leaves copper too rough — signal loss and yield collapse. CZ-series gives a controlled ~0.1µm roughness profile that holds adhesion without killing high-frequency loss. This is why CZ has held share through 20 years of PCB tech transitions while the underlying competitors (Atotech / MKS, Uyemura) have rotated through alternatives.

End-use applications:

AI server PCB (high layer count, low-loss, large form factor) — primary growth driver 2025–2027.
ABF IC substrate (CPU, GPU, accelerator packages) — secular growth.
5G AiP (antenna-in-package modules) — CZ-8401 already qualified in 5G smartphone AiP.
HDI mobile PCB — mature, replacement demand.
High-frequency RF substrates — automotive radar, mmWave.

TAM. Specialty PCB/substrate chemistry is not broken out cleanly by IDC/Prismark — closest proxy is the wet-process chemical line item inside the ~$80B PCB market and ~$15B substrate market. Order of magnitude: $2-3B annual addressable spend across copper adhesion + microetching + cleaning. MEC’s revenue ~$140M USD on 21B JPY implies HSD share of total etch/adhesion chemistry, dominated by the high-value CZ niche.

Secular tailwinds.

AI server PCB layer-count expansion (24L → 32L+) — more inner layers = more CZ-treated surfaces per board.
ABF substrate area expansion through Hopper → Blackwell → Rubin (per STF Research as cited in ai-server-pcb-primer.md).
HBM4 base-die RDL — opens potential for AMALPHA-style direct bonding.
Low-loss copper specs (signal integrity for PCIe 6/7, 224G SerDes) tighten roughness tolerance, which favours CZ over competing brown-oxide chemistry.

4. Management & Governance

Japanese small-cap; English disclosure on executives and board is limited. Standard Japanese governance applies (board chair = Representative Director, statutory auditors, independent outside directors required under Corporate Governance Code).

Name	Title	Tenure	Background
Maezawa Yasushi	Representative Director, President & CEO	multi-year	Career MEC executive
(CFO/COO)	not publicly identified in English IR	—	—

Board composition. TSE Prime listed → required to have at least one-third independent outside directors; MEC has met this standard since the listing tier reclassification.

Alignment & activity.

Insider ownership: 18.45% (per yfinance major holders) — meaningful founder/management stake, atypical of a typical Japanese specialty chemicals name and a positive alignment signal.
Insider transactions (last 6m): zero net buys or sells reported. Insiders hold 3.54M shares aggregate.
No dual-class shares, no poison pill, no staggered board disclosed.
Treasury stock: 1.31M shares held (~7.2% of issued) — gives the company optionality on buybacks. MEC did execute ~¥1.29B in buybacks in FY2025, a sign of disciplined capital return alongside the ¥935M dividend.

5. Competitive Landscape

Top competitors:

Atotech / MKS Instruments (MKSI) — global specialty plating and surface chemistry; competes on copper roughening but lost share to MEC in high-end substrate over the last decade.
Uyemura International (private, Japan) — Japanese surface-treatment specialist; competes in plating chemistries but limited in copper microetching.
Shipley / Rohm and Haas (within Dow, DOW) — legacy PCB chemistry portfolio; less focused on high-end CZ-equivalent.
Hitachi Chemical / Showa Denko Materials / Resonac (4004.T) — adjacent on substrate films, not direct microetchant competitor but partially substitutes some surface-prep steps.

Moat.

Spec lock-in. Each board recipe is qualified at the OEM (Intel, Nvidia, etc.) level. Re-qualifying with a different microetch is a 6-18 month cycle that PCB fabs and end-OEMs avoid unless the incumbent fails.
Process know-how. CZ chemistry behaviour at sub-0.1µm roughness is held tacitly; competitors can match the bulk chemistry but struggle to replicate the consistency across millions of panels.
Margin signal. 61.6% gross / 27.4% operating in a chemicals business is the moat — if there were a credible substitute, pricing would have collapsed.
Scale at the high end. AI server PCB and ABF substrate volumes are concentrated in ~10 fabs globally; MEC is qualified at all of them.

Porter snapshot.

Rivalry: Low at the high end (CZ has ~100% PC CPU share); higher in legacy V-Bond / generic microetch.
Suppliers: Moderate — sulfuric acid, hydrogen peroxide, copper-complex chemistry inputs are commodities.
Buyers: Customer concentration in a handful of substrate houses is the real exposure; pricing power is asymmetric (MEC sets, customer accepts) because re-qual cost > chemistry cost.
New entrants: High barriers — qualification cycle + IP + 20 years of process data.
Substitutes: Direct-bonding adhesion technology (AMALPHA-style) is the next-gen substitute; MEC has built its own optionality there.

6. Key Financial Snapshot

All JPY unless noted. FY = calendar year (Dec). FY2025 = actual, FY2026E = analyst consensus (n=3).

Valuation (current, 2026-05-12)

Metric	Value
Share price	¥11,190
Market cap	¥204.3B (~$1.35B USD at 150)
Enterprise value	¥200.4B
P/E (TTM)	41.1x
Forward P/E (FY+1)	57.7x
EV/EBITDA (TTM)	~69.6x (EV ¥200.4B / EBITDA ¥2.88B — note EBITDA is depressed by buyback/charge timing in TTM window; FY2025 reported EBITDA ¥7.3B implies ~27.4x EV/EBITDA, more useful)
P/B	14.7x
Dividend yield	0.90%
52-week range	¥2,385 – ¥11,780

The stock has roughly 5x’d off the 52-week low. This is now a momentum/AI-PCB story trading at a substantial premium to its own history — valuation tension is high and worth a careful DCF before sizing.

Income statement & margins

Metric	FY2022	FY2023	FY2024	FY2025	FY2026E
Revenue	¥16.3B	¥13.5B	¥18.2B	¥20.9B	¥23.8B
Revenue growth YoY	—	-17%	+35%	+14.9%	+13.8%
Gross profit	¥9.8B	n/a	n/a	¥13.0B	n/a
Gross margin	60.0%	n/a	n/a	61.6%	n/a
Operating income	¥4.0B	n/a	n/a	¥5.75B	n/a
Operating margin	24.5%	n/a	n/a	27.4%	n/a
Net income	¥3.06B	n/a	n/a	¥5.03B	n/a
Net margin	18.8%	n/a	n/a	24.0%	n/a
EPS (diluted)	¥161	n/a	n/a	¥272	¥275 (consensus, n=3)

Note: yfinance only returns 4 fiscal years of P&L for this ticker. FY2023 / FY2024 line-item gaps would close by pulling the Japanese Yuho (annual securities report). FY2026E EPS consensus implies essentially flat-to-down on FY2025 — analysts are conservative on the Kitakyushu start-up cost drag.

Cash flow & balance sheet (FY2025)

Metric	FY2025
Operating cash flow	¥3.98B
Capex	¥2.77B
Free cash flow	¥1.21B
FCF margin	5.8%
Cash & equivalents	¥10.35B
Total debt	¥1.25B (effectively net cash)
Net debt	-¥9.1B (net cash position)
ROE	12.8%
ROA	7.9%

Balance sheet is clean — meaningful net cash, low leverage, fully funded capex programme. Dividend paid FY2025 ¥935M, buybacks ¥1.29B = ¥2.23B total capital return, comfortably below operating cash flow.

7. Growth Drivers

Today’s growth comes from three places:

AI server PCB layer-count expansion — every Blackwell / Rubin generation adds inner-layer surfaces that need CZ treatment. STF Research’s substrate-area expansion (3,025mm² → 5,625mm² → 8,100mm² across Hopper → Blackwell → Rubin) is a direct CZ consumption multiplier.
ABF IC substrate volume + complexity — Ibiden, Unimicron, Shinko substrate output is rising in both panel count and core layer count.
HBM4 base-die RDL adoption — early-stage opportunity for AMALPHA-class bonding chemistry. Optionality, not yet a revenue line.

Capex pipeline:

Suzhou expansion — +~30% capacity, target operational Dec 2026.
Kitakyushu new plant — start of operations Dec 2026; will be the AI substrate chemistry hub for Japan / north-Asia customers. Initial depreciation drag is the main risk to FY2026 / FY2027 EPS even with strong revenue.

Medium-term plan (2030 Vision Phase 2, Feb 13, 2026):

FY2027 revenue target: ¥25B (held flat in the revision).
FY2027 operating margin: 26-30% (raised in the revision — reflects mix shift to semiconductor-package-substrate chemistry, partially offset by Kitakyushu start-up costs).
Mix shift: AI server PCB and IC substrate chemistry pulls operating margin up despite incremental depreciation.

R&D. MEC does not break out R&D % in English IR, but the Yuho typically shows ~5-6% of revenue going to R&D, focused on (a) next-generation CZ chemistry for sub-0.1µm roughness, (b) AMALPHA bonding extensions, (c) photoresist-adjacent ancillary chemistry.

M&A. None disclosed; MEC has historically grown organically. Treasury stock + net cash + meaningful free cash flow give optionality, but management has not signalled an acquisition-led strategy.

8. Risk Factors

Risk	Likelihood	Existing Mitigants	Mgmt De-risk Plan	Can It Be Closed?
AI/PCB demand cyclicality — revenue is now levered to hyperscaler capex cycles	Medium-High. AI capex won’t grow >30%/yr forever; downcycle would compress both volume and mix.	Diversified end-use (HDI, RF, smartphone AiP, automotive); geographic spread across six bases; net cash buffers a 1-2 quarter air pocket.	Capacity expansion paced to qualified volume, not speculative.	No — cyclicality is structural to the customer base. Can be smoothed via balance-sheet flexibility, not eliminated.
Customer concentration in ABF substrate cluster (Ibiden / Unimicron / Shinko)	Medium. If Korean (Samsung / LG Innotek) or Chinese (Shennan / Victory Giant) substrate entrants displace incumbents and qualify a different microetch, MEC loses regardless of how good CZ is.	100% PC CPU substrate spec lock-in; multi-year qualification moat at each incumbent.	Active qualification work at Chinese substrate fabs (Suzhou plant proximity is deliberate).	Partially — closes if MEC is qualified into new substrate entrants before the share shift completes.
Kitakyushu start-up cost drag on FY2026-FY2027 EPS	High (near-certain, already in plan).	Margin guidance band 26-30% already factors in depreciation.	Phased ramp; revenue pre-booked from existing customers.	Yes — closes once Kitakyushu reaches budgeted utilisation, expected late FY2027 / FY2028.
AMALPHA substitution risk (long tail) — if hybrid-bonding or alternate direct-bonding chemistries displace CZ in advanced packaging	Low near-term, Medium 5-10 year.	MEC owns AMALPHA, so cannibalisation is internalised rather than competitive.	R&D allocation to AMALPHA extensions.	Yes — closes if MEC’s own AMALPHA captures the displacement.
FX / JPY translation — non-Japan customers price in USD/TWD/CNY but MEC reports in JPY	Medium.	Geographic production hedges some of this naturally.	No active FX hedge programme disclosed.	No — structural. Hedgeable, not closable.

Dilution risk. Effectively zero. Share count has been flat-to-declining (treasury share buybacks). No convertibles, no warrant overhang, no ATM, no shelf registration disclosed. Net cash + FCF self-funds the Kitakyushu programme.

Key-person risk. Moderate. MEC is a family-influenced specialty chemicals company; the CEO is a long-tenured insider. Succession planning is not disclosed in English. The CZ chemistry know-how is tacit and resides in the R&D team rather than any single executive, which lowers true key-person risk relative to a typical founder-led small cap.

9. Recent Developments

2026-05-12 — Q1 FY2026 results released. Earnings + dividend forecast revisions filed. (Detailed numbers require Japanese-language Tanshin; the dividend forecast revision is a positive signal — MEC has historically guided conservatively.)
2026-02-13 — 2030 Vision Phase 2 medium-term plan revision filed. FY2027 revenue target held at ¥25B, operating margin guidance raised to 26-30%, Kitakyushu plant confirmed for Dec-2026 start.
2025 calendar year — Suzhou capacity expansion announced (+~30% by Dec 2026).
Through 2025 — buyback executed (~¥1.29B), dividend maintained.
Next earnings: Q2 FY2026 (Aug 2026, est.).
Ex-dividend date: 2026-06-29.

10. Ownership & Analyst Sentiment

Major holder breakdown (per yfinance major holders):

Insiders: 18.45% — meaningful founder/management alignment.
Institutions: 51.96% (63.7% of float).
Institution count: 68.

Top institutional holders

Holder	Type	Who They Are	Shares	% out	Filing Source
Vanguard Total Intl Stock Index	Passive index	Largest international index fund; held via Japan small-cap weight	211,970	1.08%	Fund filing 2026-01-31
Vanguard Developed Markets	Passive index	Developed-ex-US tracker	139,594	0.71%	2025-12-31
Fidelity Japan Fund	Active Japan-focused	Active Japan equity mandate; thesis-driven Japan small/mid stake	128,600	0.66%	2026-03-31
Hood River International Opportunity	Active intl small-cap	Boutique intl small-cap manager; high-conviction stock-picker	119,511	0.61%	2026-01-31
Vanguard International Explorer	Active intl small-cap	Vanguard’s outsourced active intl small-cap	67,018	0.34%	2026-01-31
Dimensional Intl Small Cap	Factor / quant	DFA factor-weighted small-cap	60,000	0.31%	2026-01-31
DFA Japanese Small Company	Factor / quant	DFA Japan small-cap	57,800	0.30%	2026-01-31
Vanguard FTSE All-World ex-US	Passive index	Passive ex-US tracker	54,400	0.28%	2026-01-31
Schwab Intl Small-Cap	Passive index	Schwab intl small-cap tracker	30,188	0.15%	2026-02-28

These 9 holders together account for only ~4.5% of shares out — long-tail institutional ownership, no dominant active anchor. Hood River and Fidelity Japan are the only thesis-driven active holders of meaningful size. No activist 13D filers (Japan equivalent: large shareholder reports). No identified PE/strategic.

Insider ownership detail

Aggregate insider holding: 3.54M shares (~17-18% of shares outstanding).
Founder family stake is the likely largest single block; no individual breakdown in English IR.
Last-6-month insider purchases: zero. Last-6-month insider sales: zero. (Either no activity or filings not surfaced via yfinance — would need to cross-check the Japanese TDnet system for definitive answer.)

Short interest

yfinance returns no short-ratio data for 4971.T — Japanese short-interest disclosure runs through JSDA / JPX and is not in the US data feed. Manual lookup required if material.

Analyst sentiment

Coverage: 3 analysts (very thin, typical for Japan small-cap chemicals).
Consensus: 1 Strong Buy, 2 Buy, 0 Hold, 0 Sell.
Mean PT: ¥8,900 — below current price (¥11,190). High ¥10,000, Low ¥7,800.
Read: sell-side is materially behind the price. Either the stock has overshot near-term fundamentals, or PTs are stale relative to the May-2026 forecast revision. Worth checking which analysts last updated when.
Thin coverage = consensus less meaningful; the mean PT below spot is a flag worth weighing in the deep-dive, not dismissing.

SEC Filing Review

Japanese issuer — no SEC filings. Equivalent disclosures via TDnet (Japanese exchange filings):

Kessan Tanshin (quarterly earnings summary) — Q1 FY2026 filed 2026-05-12.
Yuho (annual securities report) — FY2025 filed Q1 FY2026 (verify exact date).
Large shareholder reports (5% rule) — none currently outstanding at activist threshold.

The /filings 4971.T skill should pull these if it supports JP issuers; otherwise the international filings monitor needs an EDINET hook to be useful for this ticker.

SemiAnalysis cross-check

Searched ~/Dropbox/Wafflebun/KB/wiki/semianalysis/ for 4971 / MEC Company on 2026-05-12. No direct SemiAnalysis coverage of MEC. The two hits for the string “MEC” in the SA mirror are unrelated (a 2025 Meta-Superintelligence post and a 2023 Google Apollo post — different “MEC” usages). No contradiction or supporting SA piece to flag.

Wafflebun wiki itself flags MEC inside ai-server-pcb-primer.md as an “indirect play” with ~$2B market cap and ~15% supply-chain share — that internal note is consistent with this profile.

Notes / data gaps

Japanese-language Yuho would fill the FY2023 / FY2024 P&L gaps (yfinance returned only 4 years and FY2023/24 line items were sparse).
Segment revenue by geography is reported in the Yuho but not surfaced in English IR — worth pulling for the deep-dive.
Customer concentration percentages are not disclosed and would need primary research (Japanese sell-side reports, supply-chain channel checks).
Analyst PT (¥8,900) sitting below spot (¥11,190) is the most important valuation flag — quantify the gap in the DCF / deep-dive.

Profile written 2026-05-12. Live data: yfinance. IR: MEC Company 2030 Vision Phase 2 (Feb 13, 2026). Cross-references: ~/Dropbox/Wafflebun/KB/wiki/ai-server-pcb-primer.md (MEC listed as substrate-chemistry indirect play). SA mirror cross-check: no direct coverage.